PARAMUS, N.J., November 6, 2019 – PGI Holding Corporation (PsychoGenics) announced that it has been awarded an Indefinite Delivery Indefinite Quantity contract by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), Department of Health and Human Services, for the screening of investigational agents through the “NINDS Preclinical Screening Platform for Pain” (PSPP). The maximum value of the contract is $49.9 million over a five-year ordering period. This project has been funded in whole or in part with Federal funds from NINDS, NIH, Department of Health and Human Services, under Contract Number 75N95019D00026.